JARROD KEARNEY: Open Payments
NPI 1194359018 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 20 payments from 9 companies in 2025. Trend: 2023 $313 · 2024 $261 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Amgen Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Exact Sciences Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $30 |
| Almatica Pharma LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: PREVNAR 20, OTEZLA, The Cologuard Plus Collection Kit, BREZTRI, MOUNJARO, Veozah, LOREEV XR, Kerendia.
Industry payments across FL — which companies pay providers there.
